{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:45:28Z","timestamp":1781333128731,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00115-024-01621-9","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T15:02:28Z","timestamp":1708700548000},"page":"329-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose","Pregnancy and breastfeeding in women with multiple sclerosis"],"prefix":"10.1007","volume":"95","author":[{"given":"Laura","family":"Witt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"1621_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-3016.2010.01147.x","volume":"25","author":"AA Khan","year":"2011","unstructured":"Khan\u00a0AA, Rodriguez\u00a0A, Kaakinen\u00a0M et\u00a0al (2011) Does in utero exposure to synthetic glucocorticoids influence birthweight, head circumference and birth length? A\u00a0systematic review of current evidence in humans. Paediatr Perinat Epidemiol 25:20\u201336","journal-title":"Paediatr Perinat Epidemiol"},{"key":"1621_CR2","doi-asserted-by":"crossref","unstructured":"Andersen ML, J\u00f8lving LR, Stenager E et\u00a0al (2023) Maternal multiple sclerosis and health outcomes among the children: a\u00a0systematic review. Clin Epidemiol: 375\u2013389","DOI":"10.2147\/CLEP.S392273"},{"key":"1621_CR3","doi-asserted-by":"crossref","unstructured":"Anderson A, Rowles W, Poole S et\u00a0al (2023) Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions. Ann Clin Transl Neurol","DOI":"10.1002\/acn3.51893"},{"key":"1621_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0890334414566237","volume":"31","author":"TE Baker","year":"2015","unstructured":"Baker\u00a0TE, Cooper\u00a0SD, Kessler\u00a0L et\u00a0al (2015) Transfer of natalizumab into breast milk in a\u00a0mother with multiple sclerosis. J\u00a0Hum Lact 31:233\u2013236","journal-title":"J Hum Lact"},{"key":"1621_CR5","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1080\/14656566.2020.1799977","volume":"21","author":"E Baldin","year":"2020","unstructured":"Baldin\u00a0E, Lugaresi\u00a0A (2020) Ponesimod for the treatment of relapsing multiple sclerosis. Expert Opin Pharmacother 21:1955\u20131964","journal-title":"Expert Opin Pharmacother"},{"key":"1621_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","volume":"43","author":"G Bandoli","year":"2017","unstructured":"Bandoli\u00a0G, Palmsten\u00a0K, Smith\u00a0CJF et\u00a0al (2017) A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am 43:489\u2013502","journal-title":"Rheum Dis Clin North Am"},{"key":"1621_CR7","unstructured":"(2019) Bfarm Rote-Hand-Brief zu \u25bcFingolimod (Gilenya\u00ae): Neue Kontraindikation bei Anwendung w\u00e4hrend der Schwangerschaft und bei Frauen im geb\u00e4rf\u00e4higen Alter. https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2019\/rhb-gilenya.html. Zugegriffen: 19. Juli 2023"},{"key":"1621_CR8","unstructured":"Biogen Netherlands BV (2021) Vumerity 231\u202fmg magensaftresistente Hartkapseln. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vumerity-epar-product-information_de.pdf. Zugegriffen: 25. Juli 2023"},{"key":"1621_CR9","first-page":"205521732210857","volume":"8","author":"SY Chey","year":"2022","unstructured":"Chey\u00a0SY, Kermode\u00a0AG (2022) Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis. Mult Scler J Exp Transl Clin 8:20552173221085737","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"1621_CR10","doi-asserted-by":"publisher","first-page":"175628642096841","DOI":"10.1177\/1756286420968414","volume":"13","author":"AI Ciplea","year":"2020","unstructured":"Ciplea\u00a0AI, Datta\u00a0P, Rewers-Felkins\u00a0K et\u00a0al (2020) Dimethyl fumarate transfer into human milk. Ther Adv Neurol Disord 13:1756286420968414","journal-title":"Ther Adv Neurol Disord"},{"key":"1621_CR11","doi-asserted-by":"crossref","unstructured":"Ciplea AI, Langer-Gould A, De Vries A et\u00a0al (2020) Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 7:","DOI":"10.1212\/NXI.0000000000000723"},{"key":"1621_CR12","doi-asserted-by":"crossref","unstructured":"Datta P, Ciplea AI, Rewers-Felkins K et\u00a0al (2020) Cladribine transfer into human milk: a\u00a0case report. Multiple Scler\u00a0J (1352458520912173)","DOI":"10.1177\/1352458520912173"},{"key":"1621_CR13","doi-asserted-by":"crossref","unstructured":"Dobson R, Rog D, Ovadia C et\u00a0al (2022) Anti-CD20 therapies in pregnancy and breast feeding: a\u00a0review and ABN guidelines. Pract Neurol","DOI":"10.1136\/pn-2022-003426"},{"key":"1621_CR14","volume-title":"Therapeutic Plasma Exchange and Pregnancy in Women with Multiple Sclerosis\u2014a\u00a0Case Series. ANZAN","author":"K Dost-Kovalsky","year":"2022","unstructured":"Dost-Kovalsky\u00a0K, Thiel\u00a0S, Ciplea\u00a0A et\u00a0al (2022) Therapeutic Plasma Exchange and Pregnancy in Women with Multiple Sclerosis\u2014a\u00a0Case Series. ANZAN. Melbourne"},{"key":"1621_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/13524585221131486","volume":"29","author":"K Dost-Kovalsky","year":"2023","unstructured":"Dost-Kovalsky\u00a0K, Thiel\u00a0S, Ciplea\u00a0AI et\u00a0al (2023) Cladribine and pregnancy in women with multiple sclerosis: the first cohort study. Mult Scler 29:461\u2013465","journal-title":"Mult Scler"},{"key":"1621_CR16","unstructured":"European Medicines Agency. Mavenclad. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mavenclad-epar-product-information_en.pdf. Zugegriffen: 25. Aug. 2023"},{"key":"1621_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10072-017-2999-1","volume":"38","author":"D Ferraro","year":"2017","unstructured":"Ferraro\u00a0D, Simone\u00a0AM, Adani\u00a0G et\u00a0al (2017) Definitive childlessness in women with multiple sclerosis: a\u00a0multicenter study. Neurol Sci 38:1453\u20131459","journal-title":"Neurol Sci"},{"key":"1621_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40120-015-0033-1","volume":"4","author":"R Gold","year":"2015","unstructured":"Gold\u00a0R, Phillips\u00a0JT, Havrdova\u00a0E et\u00a0al (2015) Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience. Neurol Ther 4:93\u2013104","journal-title":"Neurol Ther"},{"key":"1621_CR19","doi-asserted-by":"crossref","unstructured":"Haben S, Ciplea AI, Tokic M et\u00a0al (2023) Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis. J\u00a0Neurol Neurosurg Psychiatry","DOI":"10.1136\/jnnp-2023-331525"},{"key":"1621_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/bfm.2011.0044","volume":"7","author":"TW Hale","year":"2012","unstructured":"Hale\u00a0TW, Siddiqui\u00a0AA, Baker\u00a0TE (2012) Transfer of interferon beta-1a into human breastmilk. Breastfeed Med 7:123\u2013125","journal-title":"Breastfeed Med"},{"key":"1621_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1756285608100416","volume":"2","author":"K Hellwig","year":"2009","unstructured":"Hellwig\u00a0K, Beste\u00a0C, Schimrigk\u00a0S et\u00a0al (2009) Immunomodulation and postpartum relapses in patients with multiple sclerosis. Ther Adv Neurol Disord 2:7\u201311","journal-title":"Ther Adv Neurol Disord"},{"key":"1621_CR22","doi-asserted-by":"crossref","unstructured":"Hellwig K, Rog D, Mcguigan C et\u00a0al (2022) Interim analysis of pregnancy outcomes after exposure to dimethyl fumarate in a\u00a0prospective international registry. Neurol Neuroimmunol Neuroinflamm 9:","DOI":"10.1212\/NXI.0000000000001114"},{"key":"1621_CR23","doi-asserted-by":"publisher","first-page":"e2144750","DOI":"10.1001\/jamanetworkopen.2021.44750","volume":"5","author":"K Hellwig","year":"2022","unstructured":"Hellwig\u00a0K, Tokic\u00a0M, Thiel\u00a0S et\u00a0al (2022) Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy. JAMA Netw Open 5:e2144750","journal-title":"JAMA Netw Open"},{"key":"1621_CR24","doi-asserted-by":"crossref","unstructured":"Hellwig K, Tokic M, Thiel S et\u00a0al (2023) Multiple sclerosis disease activity and disability following cessation of fingolimod for pregnancy. Neurol Neuroimmunol Neuroinflamm 10:","DOI":"10.1212\/NXI.0000000000200110"},{"key":"1621_CR25","doi-asserted-by":"publisher","first-page":"175628641877497","DOI":"10.1177\/1756286418774973","volume":"11","author":"F Hoffmann","year":"2018","unstructured":"Hoffmann\u00a0F, Kraft\u00a0A, Heigl\u00a0F et\u00a0al (2018) Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica. Ther Adv Neurol Disord 11:1756286418774973","journal-title":"Ther Adv Neurol Disord"},{"key":"1621_CR26","doi-asserted-by":"publisher","first-page":"103700","DOI":"10.1016\/j.msard.2022.103700","volume":"60","author":"M Houtchens","year":"2022","unstructured":"Houtchens\u00a0M, Mahlanza\u00a0T, Ciplea\u00a0AI et\u00a0al (2022) Peginterferon beta-1a concentrations in breast milk of lactating multiple sclerosis patients. Mult Scler Relat Disord 60:103700","journal-title":"Mult Scler Relat Disord"},{"key":"1621_CR27","first-page":"240","volume":"22","author":"MW Kemp","year":"2016","unstructured":"Kemp\u00a0MW, Newnham\u00a0JP, Challis\u00a0JG et\u00a0al (2016) The clinical use of corticosteroids in pregnancy. Hum Reprod Update 22:240\u2013259","journal-title":"Hum Reprod Update"},{"key":"1621_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/humrep\/deac041","volume":"37","author":"T Kopp","year":"2022","unstructured":"Kopp\u00a0T, Pinborg\u00a0A, Glazer\u00a0C et\u00a0al (2022) Women with female infertility seeking medically assisted reproduction are not at increased risk of developing multiple sclerosis. Hum Reprod 37:1324\u20131333","journal-title":"Hum Reprod"},{"key":"1621_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","volume":"22","author":"KM Krysko","year":"2023","unstructured":"Krysko\u00a0KM, Dobson\u00a0R, Alroughani\u00a0R et\u00a0al (2023) Family planning considerations in people with multiple sclerosis. Lancet Neurol 22:350\u2013366","journal-title":"Lancet Neurol"},{"key":"1621_CR30","doi-asserted-by":"publisher","first-page":"175628642093616","DOI":"10.1177\/1756286420936166","volume":"13","author":"KM Krysko","year":"2020","unstructured":"Krysko\u00a0KM, Graves\u00a0JS, Dobson\u00a0R et\u00a0al (2020) Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord 13:1756286420936166","journal-title":"Ther Adv Neurol Disord"},{"key":"1621_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jamaneurol.2019.4173","volume":"77","author":"KM Krysko","year":"2020","unstructured":"Krysko\u00a0KM, Rutatangwa\u00a0A, Graves\u00a0J et\u00a0al (2020) Association between breastfeeding and postpartum multiple sclerosis relapses: a\u00a0systematic review and meta-analysis. JAMA Neurol 77:327\u2013338","journal-title":"JAMA Neurol"},{"key":"1621_CR32","first-page":"493","volume":"25","author":"R Lamaita","year":"2021","unstructured":"Lamaita\u00a0R, Melo\u00a0C, Laranjeira\u00a0C et\u00a0al (2021) Multiple sclerosis in pregnancy and its role in female fertility: a\u00a0systematic review. JBRA Assist Reprod 25:493\u2013499","journal-title":"JBRA Assist Reprod"},{"key":"1621_CR33","doi-asserted-by":"crossref","unstructured":"Landi D, Bovis F, Grimaldi A et\u00a0al (2022) Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. J\u00a0Neurol Neurosurg Psychiatry","DOI":"10.1136\/jnnp-2022-329657"},{"key":"1621_CR34","doi-asserted-by":"publisher","first-page":"e1939","DOI":"10.1212\/WNL.0000000000009374","volume":"94","author":"A Langer-Gould","year":"2020","unstructured":"Langer-Gould\u00a0A, Smith\u00a0JB, Albers\u00a0KB et\u00a0al (2020) Pregnancy-related relapses and breastfeeding in a\u00a0contemporary multiple sclerosis cohort. Neurology 94:e1939\u2013e1949","journal-title":"Neurology"},{"key":"1621_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","volume":"172","author":"E Leray","year":"2016","unstructured":"Leray\u00a0E, Moreau\u00a0T, Fromont\u00a0A et\u00a0al (2016) Epidemiology of multiple sclerosis. Rev Neurol 172:3\u201313","journal-title":"Rev Neurol"},{"key":"1621_CR36","volume-title":"Disease Activity and Pregnancy Outcomes after different Natalizumab exposure patterns during pregnancy in women with MS\u2014Results from the German Multiple Sclerosis and Pregnancy Registry. In","author":"N Litvin","year":"2021","unstructured":"Litvin\u00a0N, Thiel\u00a0S, Haben\u00a0S et\u00a0al (2021) Disease Activity and Pregnancy Outcomes after different Natalizumab exposure patterns during pregnancy in women with MS\u2014Results from the German Multiple Sclerosis and Pregnancy Registry. DGN-Kongress, Berlin"},{"key":"1621_CR37","volume-title":"ACTRIMS-ECTRIMS. MSVirtual2020","author":"LM Prach","year":"2020","unstructured":"Prach\u00a0LM, Moore\u00a0A, Rezaallah\u00a0B et\u00a0al (2020) Cumulative update on pregnancy outcomes after fingolimod treatment in patients with multiple sclerosis. ACTRIMS-ECTRIMS. MSVirtual2020"},{"key":"1621_CR38","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2020.3937","volume":"323","author":"K R\u00e4ikk\u00f6nen","year":"2020","unstructured":"R\u00e4ikk\u00f6nen\u00a0K, Gissler\u00a0M, Kajantie\u00a0E (2020) Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA 323:1924\u20131933","journal-title":"JAMA"},{"key":"1621_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.msard.2018.06.006","volume":"24","author":"PV Rasmussen","year":"2018","unstructured":"Rasmussen\u00a0PV, Magyari\u00a0M, Moberg\u00a0JY et\u00a0al (2018) Patient awareness about family planning represents a\u00a0major knowledge gap in multiple sclerosis. Mult Scler Relat Disord 24:129\u2013134","journal-title":"Mult Scler Relat Disord"},{"key":"1621_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/0890334417706359","volume":"34","author":"C Rodriguez-Camejo","year":"2018","unstructured":"Rodriguez-Camejo\u00a0C, Puyol\u00a0A, Fazio\u00a0L et\u00a0al (2018) Antibody profile of colostrum and the effect of processing in human milk banks: implications in immunoregulatory properties. J\u00a0Hum Lact 34:137\u2013147","journal-title":"J Hum Lact"},{"key":"1621_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/cpt.676","volume":"101","author":"J Wang","year":"2017","unstructured":"Wang\u00a0J, Johnson\u00a0T, Sahin\u00a0L et\u00a0al (2017) Evaluation of the safety of drugs and biological products used during lactation: workshop summary. Clin Pharmacol Ther 101:736\u2013744","journal-title":"Clin Pharmacol Ther"},{"key":"1621_CR42","doi-asserted-by":"publisher","first-page":"106118","DOI":"10.1016\/j.clineuro.2020.106118","volume":"197","author":"S Zengin Karahan","year":"2020","unstructured":"Zengin Karahan\u00a0S, Boz\u00a0C, Terzi\u00a0M et\u00a0al (2020) Methylprednisolone concentrations in breast milk and serum of patients with multiple sclerosis treated with IV pulse methylprednisolone. Clin Neurol Neurosurg 197:106118","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01621-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01621-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01621-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T11:03:10Z","timestamp":1712919790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01621-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01621-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"19 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Witt erhielt eine Reisekosten\u00fcbernahme von Novartis Pharma GmbH. S.\u00a0Thiel erhielt Vortragshonorare von Bayer Healthcare und Biogen GmbH sowie Zahlungen f\u00fcr das Verfassen von Manuskripten von der HEXAL AG. K.\u00a0Hellwig erhielt Vortragshonorare und Forschungsunterst\u00fctzung von Bayer, Biogen, Merck, Novartis, Sanofi-Genzyme, Roche und Teva, Unterst\u00fctzung f\u00fcr die Teilnahme an Kongressen von Bayer, Biogen, Merck, Roche, Sanofi-Genzyme und Teva und war Mitglied in wissenschaftlichen Beir\u00e4ten f\u00fcr Bayer, Biogen, Sanofi, Teva, Roche, Novartis und Merck. Das Deutsche Multiple Sklerose und Kinderwunschregister wird unterst\u00fctzt durch den Innovationsfond des Gemeinsamen Bundesausschusses sowie durch die Firmen Almirall Hermal GmbH, Biogen GmbH Germany, Hexal AG, Merck Serono GmbH, Novartis Pharma GmbH, Roche Deutschland GmbH, Sanofi Genzyme and Teva GmbH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}